Location: London, United Kingdom
CIK: 0001131399 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 13, 2026
Total Value: $602M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WVE | WAVE LIFE SCIENCES LTD | 18,245,691 | $106M | 17.6% | $10.16 | — | SHS | Y95308105 |
| CRSP | CRISPR THERAPEUTICS AG | 3,220,627 | $176M | 29.2% | $59.89 | — | NAMEN AKT | H17182108 |
| VIR | VIR BIOTECHNOLOGY INC | 8,550,954 | $87.13M | 14.5% | $5.95 | — | COM | 92764N102 |
| LYEL | LYELL IMMUNOPHARMA INC | 1,512,659 | $21.25M | 3.5% | $22.38 | — | COM NEW | 55083R203 |
| FULC | FULCRUM THERAPEUTICS INC | 1,785,714 | $6.536M | 1.1% | $10.18 | — | COM | 359616109 |
| CYTK | CYTOKINETICS INC | 340,434 | $29M | 4.8% | $62.21 | — | COM NEW | 23282W605 |
| IDYA | IDEAYA BIOSCIENCES INC | 1,333,333 | $49.69M | 8.3% | $31.88 | — | COM | 45166A102 |
| CVRX | CVRX INC | 1,007,583 | $5.179M | 0.9% | $9.13 | — | COM | 126638105 |
| BNTX | BIONTECH SE | 889,824 | $82.8M | 13.7% | $95.20 | — | SPONSORED ADS | 09075V102 |
| NKTX | NKARTA INC | 3,150,732 | $8.917M | 1.5% | $2.00 | — | COM | 65487U108 |
| SPRO | SPERO THERAPEUTICS INC | 9,190,606 | $20.31M | 3.4% | $2.32 | — | COM | 84833T103 |
| RGNX | REGENXBIO INC | 271,456 | $3.252M | 0.5% | $12.46 | — | COM | 75901B107 |
| BCYC | BICYCLE THERAPEUTICS PLC | 1,529,561 | $6.485M | 1.1% | $7.08 | — | SPONSORED ADS | 088786108 |